Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jacobs
D van Steenberghe

Showing results (721-730 of 3,472) with videos related to

Pageof 348
Sort By:
The Journal of Antimicrobial Chemotherapy|February 1, 1997
Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other beta-lactamsS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|April 1, 1997
Bactericidal activity of DU-6859a compared to activities of three quinolones, three beta-lactams, clindamycin, and metronidazole against anaerobes as determined by time-kill methodologyS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|September 1, 1996
MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococciG A Pankuch, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|June 13, 1998
Postantibiotic effect of trovafloxacin against gram-positive and -negative organismsG A Pankuch, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|January 7, 1998
Antipneumococcal activity of BAY 12-8039, a new quinolone, compared with activities of three other quinolones and four oral beta-lactamsM A Visalli, M R Jacobs, P C Appelbaum
Journal of Immunology (Baltimore, Md. : 1950)|March 3, 2010
IL-7 is essential for homeostatic control of T cell metabolism in vivoSarah R Jacobs, Ryan D Michalek, Jeffrey C Rathmell
International Journal of Oral and Maxillofacial Surgery|February 22, 2023
Cumulative exposure and lifetime cancer risk from diagnostic radiation in patients undergoing orthognathic surgery: a cross-sectional analysisJ Ver Berne, C Politis, E Shaheen, et al.
Antimicrobial Agents and Chemotherapy|July 8, 2020
Characterization of Large Deletion Mutants of Mycobacterium tuberculosis Selected for Isoniazid ResistanceCatherine Vilchèze, Rajagopalan Saranathan, Brian Weinrick, et al.
Frontiers in Endocrinology|June 19, 2012
The primary cilium as a novel extracellular sensor in boneDavid A Hoey, Julia C Chen, Christopher R Jacobs
Antimicrobial Agents and Chemotherapy|September 16, 1998
Activities of gatifloxacin compared to those of seven other agents against anaerobic organismsL M Ednie, M R Jacobs, P C Appelbaum
Pageof 348

Showing results (721-730 of 3,472) with videos related to

Sort By:
Pageof 348
The Journal of Antimicrobial Chemotherapy|February 1, 1997
Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other beta-lactamsS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|April 1, 1997
Bactericidal activity of DU-6859a compared to activities of three quinolones, three beta-lactams, clindamycin, and metronidazole against anaerobes as determined by time-kill methodologyS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|September 1, 1996
MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococciG A Pankuch, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|June 13, 1998
Postantibiotic effect of trovafloxacin against gram-positive and -negative organismsG A Pankuch, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|January 7, 1998
Antipneumococcal activity of BAY 12-8039, a new quinolone, compared with activities of three other quinolones and four oral beta-lactamsM A Visalli, M R Jacobs, P C Appelbaum
Journal of Immunology (Baltimore, Md. : 1950)|March 3, 2010
IL-7 is essential for homeostatic control of T cell metabolism in vivoSarah R Jacobs, Ryan D Michalek, Jeffrey C Rathmell
International Journal of Oral and Maxillofacial Surgery|February 22, 2023
Cumulative exposure and lifetime cancer risk from diagnostic radiation in patients undergoing orthognathic surgery: a cross-sectional analysisJ Ver Berne, C Politis, E Shaheen, et al.
Antimicrobial Agents and Chemotherapy|July 8, 2020
Characterization of Large Deletion Mutants of Mycobacterium tuberculosis Selected for Isoniazid ResistanceCatherine Vilchèze, Rajagopalan Saranathan, Brian Weinrick, et al.
Frontiers in Endocrinology|June 19, 2012
The primary cilium as a novel extracellular sensor in boneDavid A Hoey, Julia C Chen, Christopher R Jacobs
Antimicrobial Agents and Chemotherapy|September 16, 1998
Activities of gatifloxacin compared to those of seven other agents against anaerobic organismsL M Ednie, M R Jacobs, P C Appelbaum
Pageof 348